AKBA - Akebia Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - AKBA (1517022)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear
24 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2023-05-25
AKBAHadas Nicole R.SVP, GCS - Sale+OE$1.22-63,186524,344-11%-$77,270
D
2023-05-25
AKBADahan MichelSVP, COOS - Sale+OE$1.22-95,478574,037-14%-$116,760
2023-05-16
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$1.07-63,567530,487-11%-$67,890
2023-05-16
AKBASpellman David ASVP, CFO, TreasurerS - Sale$1.07-63,567446,483-12%-$67,890
2023-03-01
AKBAButler John P.CEO, PresS - Sale$0.88-91,8681,888,728-5%-$80,614
2023-03-01
AKBAHadas Nicole R.SVP, GCS - Sale$0.88-13,034287,530-4%-$11,437
2023-03-01
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$0.88-14,123594,054-2%-$12,393
2023-03-01
AKBADahan MichelSVP, COOS - Sale$0.88-20,412269,515-7%-$17,912
2023-03-01
AKBASpellman David ASVP, CFO, TreasurerS - Sale$0.88-7,210510,050-1%-$6,327
2023-02-27
AKBAButler John P.CEO, PresS - Sale$0.81-38,6321,980,596-2%-$31,416
2023-02-27
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$0.81-7,539608,177-1%-$6,131
2023-02-27
AKBADahan MichelSVP, COOS - Sale$0.81-10,090289,927-3%-$8,205
2023-02-27
AKBASpellman David ASVP, CFO, TreasurerS - Sale$0.81-7,539517,260-1%-$6,131
2023-02-27
AKBAHadas Nicole R.SVP, GCS - Sale$0.81-6,677300,564-2%-$5,430
2022-08-31
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale$0.36-1,147418,0160%-$416
2022-06-03
AKBAGilman Steven CDirS - Sale$0.36-4,56743,430-10%-$1,653
DM
2022-02-28
AKBAButler John P.CEO, PresS - Sale+OE$2.17-79,0261,723,103-4%-$171,143
DM
2022-02-28
AKBABurke Steven KeithSVP, Chief Medical OfficerS - Sale+OE$2.16-15,056217,663-6%-$32,564
D
2022-02-28
AKBACotreau ViolettaSVP, Chief Accounting OfficerS - Sale+OE$2.15-3,94669,954-5%-$8,503
DM
2022-02-28
AKBADahan MichelSVP, COOS - Sale+OE$2.17-21,533297,017-7%-$46,637
DM
2022-02-28
AKBAFaulkingham DellSVP, CCOS - Sale+OE$2.16-13,184173,841-7%-$28,515
DM
2022-02-28
AKBAHadas Nicole R.SVP, GCS - Sale+OE$2.17-21,062304,241-6%-$45,615
DM
2022-02-28
AKBASpellman David ASVP, CFO, TreasurerS - Sale+OE$2.16-8,203128,599-6%-$17,689
2022-01-03
AKBACotreau ViolettaSVP, Chief Accounting OfficerS - Sale$2.29-5,83333,067-15%-$13,335

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top